pharma commercial analytics

H1 vs IQVIA: Which HCP Data Platform Fits Your Pharma Commercial Team in 2026

H1 vs IQVIA for pharma commercial teams: published coverage figures, what each is built for, a scorecard, a launch example and how to test both before signing.

Market Access Analytics for Pharma: What to Measure, Build or Buy

Market access analytics explained: the questions it answers, the data each needs, a worked pull-through example, and when to buy a platform or build your own.

Veeva Compass vs IQVIA: Which Prescriber and Patient Data Fits Your Brand in 2026

Veeva Compass vs IQVIA compared product by product: published figures, licensing, what the 2025 settlement changed, and a test to run before you switch.

Pharma Incentive Compensation: Plan Design, Data and Administration in 2026

Pharma incentive compensation in 2026: benchmark pay caps, a worked payout example, the IC data pipeline, and whether to outsource, buy software or build.

Symphony Health vs IQVIA: Choosing Prescription Data After the HealthVerity Deal

Symphony Health vs IQVIA: published coverage, what the 2026 HealthVerity deal changes, which fits targeting or incentive pay, and how to test a switch.

Pharma Launch Analytics: Metrics, Data and a 20-Week Build Plan

Pharma launch analytics for specialty brands: the metrics that matter, which data answers each, costs, a 20-week build plan and when not to buy a platform.

Komodo Health vs IQVIA: Which Patient Claims Data Fits Your Brand in 2026

Komodo Health vs IQVIA: published data figures, open vs closed claims, which fits your brand, and a test to run on both before you sign a data contract.

Commercial analytics problems pharma teams still struggle with in 2026

Commercial analytics problems pharma teams still struggle with in 2026 Pharma organizations have more data than ever before. Sales activity, prescription trends, access metrics, patient services...